ArticleEuropean urology2020

The New Standard Adjuvant Treatment for High-risk Stage 1 Nonseminoma: Reducing the Treatment Burden and Maximizing Long-term Survival.

Torgrim TandstadPubMed ↗Publisher ↗

No numbers read from the abstract.